Related references
Note: Only part of the references are listed.The current state of knowledge on age, sex, and their interactions on clinical pharmacology
J. B. Schwartz
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effect of conjugated equine estrogens on oxidative metabolism in middle-aged and elderly postmenopausal women
Mary Beth O'Connell et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Opioid analgesic involvement in drug abuse deaths in American metropolitan areas
Leonard J. Paulozzi
AMERICAN JOURNAL OF PUBLIC HEALTH (2006)
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism
HK Lee et al.
CLINICA CHIMICA ACTA (2006)
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites
Bojan Lalovic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Population pharmacokinetics of oxycodone in children 6 months to 7 years old
A El-Tahtawy et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
CYP2D6 genotyping by a multiplex primer extension reaction
J Sistonen et al.
CLINICAL CHEMISTRY (2005)
Marked variation in oxycodone pharmacokinetics in infants
ML Pokela et al.
PEDIATRIC ANESTHESIA (2005)
Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes
B Lalovic et al.
DRUG METABOLISM AND DISPOSITION (2004)
Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children
H Kokki et al.
CLINICAL PHARMACOKINETICS (2004)
Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio
K Ohara et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: Comparison with fluoxetine and quinidine
KM Bertelsen et al.
DRUG METABOLISM AND DISPOSITION (2003)
Safety and efficacy of controlled-release oxycodone: A systematic literature review
DG Rischitelli et al.
PHARMACOTHERAPY (2002)
Share Paper
